Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Greil

Showing results (231-240 of 483) with videos related to

Pageof 49
Sort By:
Breast Cancer Research and Treatment|July 29, 2008
The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancerRupert Bartsch, Brigitte Mlineritsch, Michael Gnant, et al.
Journal of the National Cancer Institute|December 13, 2007
Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6aRaimund Jakesz, Richard Greil, Michael Gnant, et al.
Leukemia|July 31, 2020
RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemiaFranz J Gassner, Nadja Zaborsky, Ilana Buchumenski, et al.
Annals of Hematology|February 26, 2011
Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patientsMichael Fiegl, Florian Falkner, Michael Steurer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2022
Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast CancerChristian F Singer, , Frederik Holst, et al.
Oncoimmunology|January 4, 2018
TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemiaKemal Catakovic, Franz Josef Gassner, Christoph Ratswohl, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 30, 2011
Antimyeloma activity of the sesquiterpene lactone cnicin: impact on Pim-2 kinase as a novel therapeutic targetKarin Jöhrer, Marlene Obkircher, Daniel Neureiter, et al.
Anticancer Research|November 5, 2014
Preoperative treatment with capecitabine, cetuximab and radiotherapy for primary locally advanced rectal cancer--a phase II clinical trialWolfgang Eisterer, Alexander De Vries, Dietmar Öfner, et al.
Oncotarget|October 13, 2016
CCR10/CCL27 crosstalk contributes to failure of proteasome-inhibitors in multiple myelomaShanmugapriya Thangavadivel, Claudia Zelle-Rieser, Angelika Olivier, et al.
Cancers|May 16, 2023
Myeloid NGS Analyses of Paired Samples from Bone Marrow and Peripheral Blood Yield Concordant Results: A Prospective Cohort Analysis of the AGMT Study GroupBettina Jansko-Gadermeir, Michael Leisch, Franz J Gassner, et al.
Pageof 49

Showing results (231-240 of 483) with videos related to

Sort By:
Pageof 49
Breast Cancer Research and Treatment|July 29, 2008
The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancerRupert Bartsch, Brigitte Mlineritsch, Michael Gnant, et al.
Journal of the National Cancer Institute|December 13, 2007
Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6aRaimund Jakesz, Richard Greil, Michael Gnant, et al.
Leukemia|July 31, 2020
RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemiaFranz J Gassner, Nadja Zaborsky, Ilana Buchumenski, et al.
Annals of Hematology|February 26, 2011
Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patientsMichael Fiegl, Florian Falkner, Michael Steurer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2022
Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast CancerChristian F Singer, , Frederik Holst, et al.
Oncoimmunology|January 4, 2018
TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemiaKemal Catakovic, Franz Josef Gassner, Christoph Ratswohl, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 30, 2011
Antimyeloma activity of the sesquiterpene lactone cnicin: impact on Pim-2 kinase as a novel therapeutic targetKarin Jöhrer, Marlene Obkircher, Daniel Neureiter, et al.
Anticancer Research|November 5, 2014
Preoperative treatment with capecitabine, cetuximab and radiotherapy for primary locally advanced rectal cancer--a phase II clinical trialWolfgang Eisterer, Alexander De Vries, Dietmar Öfner, et al.
Oncotarget|October 13, 2016
CCR10/CCL27 crosstalk contributes to failure of proteasome-inhibitors in multiple myelomaShanmugapriya Thangavadivel, Claudia Zelle-Rieser, Angelika Olivier, et al.
Cancers|May 16, 2023
Myeloid NGS Analyses of Paired Samples from Bone Marrow and Peripheral Blood Yield Concordant Results: A Prospective Cohort Analysis of the AGMT Study GroupBettina Jansko-Gadermeir, Michael Leisch, Franz J Gassner, et al.
Pageof 49